Literature DB >> 23718741

Borderline personality disorder features and risk for prescription opioid use disorders.

Sarah L Tragesser1, Rachel E Jones, Robert Joe Robinson, Alison Stutler, Adam Stewart.   

Abstract

Although there is evidence for high comorbidity between borderline personality disorder (BPD) and substance use disorders, particularly alcohol use, more research is needed on the associations between BPD and prescription opioid use because of the increasing national problem of prescription opioid misuse. The purpose of the present study was to examine relationships between BPD features and prescription opioid use, risk for misuse, consequences, and dependence features, and to determine which aspects of BPD account for these associations. As predicted, BPD features were associated with greater quantity and frequency of opioid use, risk for pain medication misuse, consequences, and dependence features. Additional analyses indicated that most of these effects were accounted for by the self-harm/impulsivity component of BPD. The authors conclude that individuals with more pronounced BPD features may be at risk for use and dependence on prescription opioids, and that this association may be primarily associated with the impulsivity features of BPD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23718741     DOI: 10.1521/pedi_2013_27_094

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  10 in total

1.  Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Authors:  Bradley T Kerridge; Tulshi D Saha; S Patricia Chou; Haitao Zhang; Jeesun Jung; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2015-09-02       Impact factor: 4.492

2.  The Roles of Emotion Regulation Difficulties and Impulsivity in the Associations between Borderline Personality Disorder Symptoms and Frequency of Nonprescription Sedative Use and Prescription Sedative/Opioid Misuse.

Authors:  Julia R Richmond; Matthew T Tull; Kim L Gratz
Journal:  J Contextual Behav Sci       Date:  2020-03-16

3.  Exploring the links among borderline personality disorder symptoms, trauma, and pain in patients with chronic pain disorders.

Authors:  Benjamin N Johnson; Mark A Lumley; Jennifer S Cheavens; Lindsey C McKernan
Journal:  J Psychosom Res       Date:  2020-06-01       Impact factor: 3.006

4.  The State of Overmedication in Borderline Personality Disorder: Interpersonal and Structural Factors.

Authors:  Rosa Shapiro-Thompson; Sarah K Fineberg
Journal:  Curr Treat Options Psychiatry       Date:  2022-03-04

Review 5.  Health harms of non-medical prescription opioid use: A systematic review.

Authors:  Dan Werb; Ayden I Scheim; Ayorinde Soipe; Samantha Aeby; Indhu Rammohan; Benedikt Fischer; Scott E Hadland; Brandon D L Marshall
Journal:  Drug Alcohol Rev       Date:  2022-04-18

6.  Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States.

Authors:  Tulshi D Saha; Bradley T Kerridge; Risë B Goldstein; S Patricia Chou; Haitao Zhang; Jeesun Jung; Roger P Pickering; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2016-06       Impact factor: 4.384

7.  Manifestation of Borderline Personality Symptomatology in Chronic Pain Patients Under Stress: An Understated and Exacerbated Consequence of the COVID-19 Crisis.

Authors:  Hannah Shapiro; Ronald J Kulich; Michael E Schatman
Journal:  J Pain Res       Date:  2020-06-15       Impact factor: 3.133

8.  The self-reference effect as a behavioral indicator of identity disturbances associated with borderline personality features in a non-clinical sample.

Authors:  Joseph Maffly-Kipp; Morgan N McCredie; Leslie C Morey
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2022-07-20

9.  Profile of female patients seeking in-patient treatment for prescription opioid abuse from a tertiary care drug dependence treatment centre from India.

Authors:  Prabhoo Dayal; Yatan Pal Singh Balhara
Journal:  Indian J Med Res       Date:  2016-01       Impact factor: 2.375

10.  A novel approach in the detoxification of intravenous buprenorphine dependence.

Authors:  Sukanto Sarkar; Eswaran Subramaniam; Janet Konthoujam
Journal:  Indian J Psychiatry       Date:  2016 Apr-Jun       Impact factor: 1.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.